JP Stock MarketDetailed Quotes

4892 Cyfuse Biomedical KK

Watchlist
  • 976
  • +108+12.44%
20min DelayTrading Apr 8 10:43 JST
7.99BMarket Cap-9.01P/E (Static)

Cyfuse Biomedical KK Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-10.91%54.45M
-34.86%7.3M
51.98%10.75M
-83.68%61.11M
-6.94%31.38M
38.86%11.46M
11.2M
7.07M
-47.13%374.48M
33.72M
Cost of revenue
60.89%37.6M
11.64%6.18M
43.65%4.53M
-82.43%23.37M
-36.26%5.72M
174.49%8.96M
5.54M
3.15M
-3.39%132.98M
8.97M
Gross profit
-55.36%16.85M
-80.35%1.11M
58.72%6.22M
-84.37%37.74M
3.68%25.67M
-49.95%2.5M
5.66M
3.92M
-57.68%241.5M
24.76M
Operating expense
24.18%912.98M
11.64%220.13M
34.14%236.17M
10.29%735.18M
-2.87%194.9M
6.26%167.04M
197.18M
176.06M
33.31%666.59M
200.66M
Operating profit
-28.49%-896.13M
-14.36%-219.02M
-33.58%-229.95M
-64.07%-697.44M
3.79%-169.23M
-8.11%-164.55M
-191.52M
-172.14M
-702.37%-425.09M
-175.91M
Net non-operating interest income (expenses)
7.19%-9.03M
-0.31%-5.12M
8.94%-4.76M
78.00%-9.73M
93.91%-2.4M
19.27%3M
-5.11M
-5.23M
-774.51%-44.25M
-39.34M
Non-operating interest income
1,100.00%480K
183.33%17K
8.33%13K
-2.44%40K
-12.50%7K
7.14%15K
--6K
--12K
-76.70%41K
--8K
Non-operating interest expense
-2.66%9.51M
0.00%2.42M
-19.17%2.08M
-65.01%9.77M
-89.54%2.4M
7.97%2.38M
--2.42M
--2.57M
433.50%27.93M
--22.99M
Total other finance cost
----
1.00%2.73M
0.97%2.7M
----
----
----
--2.7M
--2.67M
--16.36M
----
Net investment income
-564.29%-93K
98.90%-14K
-1.27M
8K
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
-45K
0
-38.79M
-462K
Less:Other special charges
----
----
--45K
----
----
----
----
----
--38.79M
--462K
Other non-operating income (expenses)
-70.65%35.51M
156.13%1.84M
7.21%11.07M
223.15%121M
703.26%117.7M
-14.63%-7.74M
718K
10.32M
-52.84%37.44M
14.65M
Income before tax
-48.37%-869.75M
-13.47%-222.3M
-33.91%-223.69M
-24.20%-586.19M
73.17%-53.94M
-7.85%-169.29M
-195.91M
-167.05M
-425.68%-471.95M
-201.05M
Income tax
-17.63%2.49M
4.10%635K
-43.86%585K
50.52%3.02M
36.38%686K
36.65%686K
610K
1.04M
0.00%2.01M
503K
Net income
-48.03%-872.24M
-13.44%-222.94M
-33.43%-224.28M
-24.32%-589.21M
72.90%-54.63M
-7.94%-169.98M
-196.52M
-168.09M
-431.66%-473.96M
-201.55M
Net income continuous operations
-48.03%-872.24M
-13.44%-222.94M
-33.43%-224.28M
-24.32%-589.21M
72.90%-54.63M
-7.94%-169.98M
---196.52M
---168.09M
-431.66%-473.96M
---201.55M
Noncontrolling interests
Net income attributable to the company
-48.03%-872.24M
-13.44%-222.94M
-33.43%-224.28M
-24.32%-589.21M
72.90%-54.63M
-7.94%-169.98M
-196.52M
-168.09M
-431.66%-473.96M
-201.55M
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
-48.03%-872.24M
-13.44%-222.94M
-33.43%-224.28M
-24.32%-589.21M
72.90%-54.63M
-7.94%-169.98M
-196.52M
-168.09M
-431.66%-473.96M
-201.55M
Gross dividend payment
Basic earnings per share
-43.65%-108.34
-10.33%-27.77
-31.63%-28.38
57.55%-75.42
73.20%-6.949
1.04%-21.741
-25.17
-21.56
-162.23%-177.67
-25.9286
Diluted earnings per share
-43.65%-108.34
-10.33%-27.77
-31.63%-28.38
57.55%-75.42
73.20%-6.949
1.03%-21.7436
-25.17
-21.56
-162.23%-177.67
-25.9286
Dividend per share
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(FY)Dec 31, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -10.91%54.45M-34.86%7.3M51.98%10.75M-83.68%61.11M-6.94%31.38M38.86%11.46M11.2M7.07M-47.13%374.48M33.72M
Cost of revenue 60.89%37.6M11.64%6.18M43.65%4.53M-82.43%23.37M-36.26%5.72M174.49%8.96M5.54M3.15M-3.39%132.98M8.97M
Gross profit -55.36%16.85M-80.35%1.11M58.72%6.22M-84.37%37.74M3.68%25.67M-49.95%2.5M5.66M3.92M-57.68%241.5M24.76M
Operating expense 24.18%912.98M11.64%220.13M34.14%236.17M10.29%735.18M-2.87%194.9M6.26%167.04M197.18M176.06M33.31%666.59M200.66M
Operating profit -28.49%-896.13M-14.36%-219.02M-33.58%-229.95M-64.07%-697.44M3.79%-169.23M-8.11%-164.55M-191.52M-172.14M-702.37%-425.09M-175.91M
Net non-operating interest income (expenses) 7.19%-9.03M-0.31%-5.12M8.94%-4.76M78.00%-9.73M93.91%-2.4M19.27%3M-5.11M-5.23M-774.51%-44.25M-39.34M
Non-operating interest income 1,100.00%480K183.33%17K8.33%13K-2.44%40K-12.50%7K7.14%15K--6K--12K-76.70%41K--8K
Non-operating interest expense -2.66%9.51M0.00%2.42M-19.17%2.08M-65.01%9.77M-89.54%2.4M7.97%2.38M--2.42M--2.57M433.50%27.93M--22.99M
Total other finance cost ----1.00%2.73M0.97%2.7M--------------2.7M--2.67M--16.36M----
Net investment income -564.29%-93K98.90%-14K-1.27M8K
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges) -45K0-38.79M-462K
Less:Other special charges ----------45K----------------------38.79M--462K
Other non-operating income (expenses) -70.65%35.51M156.13%1.84M7.21%11.07M223.15%121M703.26%117.7M-14.63%-7.74M718K10.32M-52.84%37.44M14.65M
Income before tax -48.37%-869.75M-13.47%-222.3M-33.91%-223.69M-24.20%-586.19M73.17%-53.94M-7.85%-169.29M-195.91M-167.05M-425.68%-471.95M-201.05M
Income tax -17.63%2.49M4.10%635K-43.86%585K50.52%3.02M36.38%686K36.65%686K610K1.04M0.00%2.01M503K
Net income -48.03%-872.24M-13.44%-222.94M-33.43%-224.28M-24.32%-589.21M72.90%-54.63M-7.94%-169.98M-196.52M-168.09M-431.66%-473.96M-201.55M
Net income continuous operations -48.03%-872.24M-13.44%-222.94M-33.43%-224.28M-24.32%-589.21M72.90%-54.63M-7.94%-169.98M---196.52M---168.09M-431.66%-473.96M---201.55M
Noncontrolling interests
Net income attributable to the company -48.03%-872.24M-13.44%-222.94M-33.43%-224.28M-24.32%-589.21M72.90%-54.63M-7.94%-169.98M-196.52M-168.09M-431.66%-473.96M-201.55M
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders -48.03%-872.24M-13.44%-222.94M-33.43%-224.28M-24.32%-589.21M72.90%-54.63M-7.94%-169.98M-196.52M-168.09M-431.66%-473.96M-201.55M
Gross dividend payment
Basic earnings per share -43.65%-108.34-10.33%-27.77-31.63%-28.3857.55%-75.4273.20%-6.9491.04%-21.741-25.17-21.56-162.23%-177.67-25.9286
Diluted earnings per share -43.65%-108.34-10.33%-27.77-31.63%-28.3857.55%-75.4273.20%-6.9491.03%-21.7436-25.17-21.56-162.23%-177.67-25.9286
Dividend per share
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP

Market Insights

Market Hot Picks Market Hot Picks
No. Symbol Price
Sample Name
Sample Code
 97.640
Sample Name
Sample Code
 233.290
Sample Name
Sample Code
 181.460
4
Palantir
PLTR
77.840
5
Amazon
AMZN
175.260
Unlock Now

Investment Course

How to Buy Stocks for Beginners
Learn stock market basics and confidently start investing with our beginner-friendly guide to buying stocks. Start your investment journey today!
What Is Options Trading and How to Trade Options
Options trading is carried out by all kinds of investors within individual investment portfolios. Learn how you can put options to work within your own portfolio.
What To Know About Margin Accounts
Discover the essentials of margin accounts, including their benefits, risks, and how to use them effectively in your trading strategy.
Cash Accounts - Covering the Basics
Discover the essentials of cash accounts. Learn what cash accounts are, how they function, their potential benefits, and the differences between cash and margin accounts.
Understanding Fractional Shares: A Beginner's Guide
Discover the basics of fractional shares, how they work, and the process for buying and selling them.

- No more -